Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Molecular screening of transitional B cells as a prognostic marker of improved graft outcome and reduced rejection risk in kidney transplant

  • Perezpayá, Inés
  • Garcia, Sergio G.|||0000-0001-7698-3734
  • Clos Sansalvador, Marta|||0000-0001-8522-7818
  • Sanroque-Muñoz, Marta|||0009-0004-5197-7708
  • Font-Morón, Miriam|||0000-0002-4714-252X
  • Rodríguez-Martínez, Paula|||0000-0002-9001-2501
  • Vila-Santandreu, Anna
  • Bover, Jordi|||0000-0003-3577-2273
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
  • Cañas, Laura
  • Franquesa, Marcella|||0000-0002-1287-8908
Understanding immune cell dynamics in kidney transplantation may provide insight into the mechanisms of rejection and improve patient management. B cells have gained interest with a special relevance of the "regulatory" subsets and their graft outcome prognostic value. In this study, we aimed to prove that the direct immunophenotyping and target gene expression analysis of kidney transplant patients' fresh whole blood will help to identify graft rejection risk and assist in the monitoring of kidney transplanted patients. We employed flow cytometry and qPCR techniques to characterize B and T cell subsets within fresh whole blood samples, with particular emphasis on transitional B cells (TrB) identified as CD19 + CD24 hi CD38 hi. TrB are a relevant population in the context of kidney transplantation and are closely associated with regulatory B cells (Bregs) in humans. Patients were monitored, tracking pertinent clinical parameters and kidney-related events, including alterations in graft function and episodes of biopsy proven rejection. Higher percentages of TrB cells at 3 months after transplantation were positively associated with better graft outcomes and lower biopsy-proven acute rejection risk. Furthermore, a novel panel of B cell regulatory associated genes was validated at 3 months post-transplantation by qPCR analysis of peripheral blood mononuclear cell (PBMC) mRNA, showing high predictive power of graft events and prognostic value. These findings suggest that monitoring TrB may provide interesting patient management information, improve transplant outcomes, and allow for personalized drug regimens to minimize clinical complications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Towards clinical translation of urinary vitronectin for non-invasive detection and monitoring of renal fibrosis in kidney transplant patients

  • Clos Sansalvador, Marta|||0000-0001-8522-7818
  • Taco, Omar|||0000-0001-9081-5665
  • Rodríguez-Martínez, Paula|||0000-0002-9001-2501
  • Garcia, Sergio G.|||0000-0001-7698-3734
  • Font-Morón, Miriam|||0000-0002-4714-252X
  • Bover, Jordi|||0000-0003-3577-2273
  • Vila-Santandreu, Anna
  • Franquesa, Marcella|||0000-0002-1287-8908
  • Juega-Mariño, Javier|||0000-0002-9927-9683
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
Interstitial fibrosis and tubular atrophy (IFTA) is a critical factor in the prognosis of kidney health. Currently, IFTA quantitation in kidney biopsy samples is crucial for diagnosis and assessing disease severity, but the available non-invasive biomarkers are not satisfactory. Proteomic studies identified urinary vitronectin (VTN) as a potential biomarker for kidney fibrosis. As mass spectrometry techniques are not practical for use in clinical settings, we tested whether evaluation of urinary VTN levels through enzyme-linked immunosorbent assay (ELISA) can help monitor fibrotic changes in kidney transplant recipients and prove the clinical viability of the assay. A total of 58 kidney transplant (KTx) patients who underwent renal biopsy were included in the study. Patients were categorized into two groups referred as no fibrosis (0%) or with fibrosis (≥ 5%) based on their histological findings. In a subsequent/follow-up analysis, the time elapsed from transplantation was also considered. The urinary levels of VTN were measured using ELISA. VTN (p = 0.0180) and VTN normalized by urinary creatinine levels (p = 0.0037), were significantly increased in patients with fibrotic grafts. When focusing on patients with long-term grafts (> 3 years from transplantation, n = 36), VTN exhibited superior potential in identifying fibrotic grafts compared to albuminuria (VTN p = 0.0040 vs. albuminuria p = 0.0132). Importantly, in this group, while albuminuria correctly identified 71% of fibrotic patients, the combination of VTN plus albuminuria correctly classified 89% of fibrotic grafts detected by renal biopsy. VTN has emerged as a valid indicator of renal fibrosis. Of interest, urinary levels of VTN in combination with conventional clinical parameters (such as albuminuria) significantly improved the non-invasive detection of renal fibrosis in kidney transplant patients. The online version contains supplementary material available at 10.1186/s12967-024-05777-5.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Regulatory B Cell Therapy in Kidney Transplantation

  • Garcia, Sergio G.|||0000-0001-7698-3734
  • Sandoval-Hellín, Noelia
  • Franquesa, Marcella|||0000-0002-1287-8908
In the context of kidney injury, the role of Bregs is gaining interest. In a number of autoimmune diseases, the number and/or the function of Bregs has been shown to be impaired or downregulated, therefore restoring their balance might be a potential therapeutic tool. Moreover, in the context of kidney transplantation their upregulation has been linked to tolerance. However, a specific marker or set of markers that define Bregs as a unique cell subset has not been found and otherwise multiple phenotypes of Bregs have been studied. A quest on the proper markers and induction mechanisms is now the goal of many researchers. Here we summarize the most recent evidence on the role of Bregs in kidney disease by describing the relevance of in vitro and in vivo Bregs induction as well as the potential use of Bregs as cell therapy agents in kidney transplantation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Agarose spot migration assay to measure the chemoattractant potential of extracellular vesicles, applications in regenerative medicine and cancer metastasis

  • Clos Sansalvador, Marta|||0000-0001-8522-7818
  • Monguió-Tortajada, Marta|||0000-0003-2125-0810
  • Grau-Leal, Ferran|||0000-0003-3072-2250
  • Ruiz de Porras, Vicenç|||0000-0002-4352-1784
  • Garcia, Sergio G.|||0000-0001-7698-3734
  • Sanroque-Muñoz, Marta
  • Font-Morón, Miriam|||0000-0002-4714-252X
  • Franquesa, Marcella|||0000-0002-1287-8908
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
The recruitment of effector cells is one of the novel functions described for extracellular vesicles (EVs) that needs further study. For instance, cell recruitment by mesenchymal stromal cell derived-EVs (MSC-EVs) is one of the features by which MSC-EVs may induce regeneration and ameliorate tissue injury. On the other hand, increasing evidence suggests that cancer EVs play an important role in the preparation of the pre-metastatic niche (PMN) by recruiting their primary tumour cells. Understanding and measuring the potential of MSC-EVs or cancer-EVs to induce cell migration and recruitment is essential for cell-free therapeutic approaches and/or for a better knowledge of cancer metastasis, respectively. In this context, classical in vitro migration assays do not completely mimic the potential situation by which EVs exert their chemotactic capacity. We adapted an agarose spot migration assay as an in vitro system to evaluate the cell recruitment capacity of locally delivered or localized EVs. Cell migration was tracked for 12 h or 48 h, respectively. Thereafter, endpoint migration images and time-lapse videos were analysed to quantify several parameters aiming to determine the migration of cells to either MSC-EV or pro-metastatic EV. The number of cells contained inside the agarose spots, the migration distance, the area occupied by cells, the directionality of the cell movement, and the Euclidean distance were measured. This multi-parametric evaluation revealed the potential of different MSC-EV preparations to recruit endothelial cells and to detect an enhanced recruitment capacity of highly metastatic PC3-derived EVs (PC3-EVs) compared to low-metastatic LNCaP-EVs in a tumour cell-specific manner. Overall, this agarose spot migration assay may offer a diversity of measurements and migration settings not provided by classical migration assays and reveal its potential use in the EV field in two different contexts with recruitment in common: regeneration and cancer metastasis. The online version contains supplementary material available at 10.1186/s12915-023-01729-5.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Process-based simulation of seasonality and drought stress in monoterpene emission models

  • Grote, R.
  • Keenan, Trevor F.|||0000-0002-3347-0258
  • Lavoir, A. V.
  • Staudt, M.
Canopy emissions of volatile hydrocarbons such as isoprene and monoterpenes play an important role in air chemistry. They depend on various environmental conditions, are highly species-specific and are expected to be affected by global change. In order to estimate future emissions of these isoprenoids, differently complex models are available. However, seasonal dynamics driven by phenology, enzymatic activity, or drought stress strongly modify annual ecosystem emissions. Although these impacts depend themselves on environmental conditions, they have yet received little attention in mechanistic modelling. In this paper we propose the application of a mechanistic method for considering the seasonal dynamics of emission potential using the "Seasonal Isoprenoid synthase Model" (Lehning et al., 2001). We test this approach with three different models (GUENTHER, Guenther et al., 1993; NIINEMETS, Niinemets et al., 2002a; BIM2, Grote et al., 2006) that are developed for simulating light-dependent monoterpene emission. We also suggest specific drought stress representations for each model. Additionally, the proposed model developments are compared with the approach realized in the MEGAN (Guenther et al., 2006) emission model. Models are applied to a Mediterranean Holm oak (Quercus ilex) site with measured weather data. The simulation results demonstrate that the consideration of a dynamic emission potential has a strong effect on annual monoterpene emission estimates. The investigated models, however, show different sensitivities to the procedure for determining this seasonality impact. Considering a drought impact reduced the differences between the applied models and decreased emissions at the investigation site by approximately 33% on average over a 10 year period. Although this overall reduction was similar in all models, the sensitivity to weather conditions in specific years was different. We conclude that the proposed implementations of drought stress and internal seasonality strongly reduce estimated emissions and indicate the measurements that are needed to further evaluate the models.